NVIDIA BioNeMo Wins Thermo Fisher, Eli Lilly as AI Drug Discovery Partners
NVIDIA secured partnerships with Thermo Fisher and Eli Lilly for its BioNeMo platform as specialized biological AI models compete against general-purpose systems in early 2026. Multiple AI platforms from Basecamp Research, Boltz Lab, Owkin, and Edison Scientific launched simultaneously, marking a shift toward purpose-built foundation models for pharmaceutical R&D.
Salvado•